FTC Asks Supreme Court To Hear Case On Antitrust Aspects Of Generic Drug Deals

Law360, New York (September 1, 2005, 12:00 AM EDT) -- In a case with wide implications for settlements of patent disputes in the drug industry, the U.S. Federal Trade Commission has asked the Supreme Court to hear its appeal of a decision by a federal appeals court that dismissed the agency’s complaints against Schering-Plough Corp.

In a March 2005 decision, the 11th Circuit Court of Appeals set aside an FTC order that barred Schering-Plough from settling an infringement suit with generic makers regarding the patented blood pressure drug K-Dur.

The FTC claims that Schering-Plough agreed to...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.